Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-30 5:46 pm Purchase |
2023-11-21 | 13G | Oscar Health, Inc. OSCR |
James E. Flynn | 10,537,491 5.520% |
10,537,491 (New Position) |
Filing History |
| 2023-11-20 3:19 pm Purchase |
2023-11-14 | 13G | MALLINCKRODT PLC SHS MNKTQ |
James E. Flynn | 1,505,969 7.650% |
1,505,969 (New Position) |
Filing History |
| 2023-11-13 4:46 pm Purchase |
2023-11-08 | 13D | Acutus Medical, Inc. AFIB |
James E. Flynn | 9,677,857 9.220% |
32,892 (+0.34%) |
Filing History |
| 2023-11-13 08:30 am Purchase |
2023-11-02 | 13G | Prelude Therapeutics Incorporated PRLD |
James E. Flynn | 3,222,690 7.680% |
3,222,690 (New Position) |
Filing History |
| 2023-10-26 4:55 pm Purchase |
2023-10-17 | 13G | Nkarta, Inc. NKTX |
James E. Flynn | 3,400,000 6.930% |
1,980,128 (+139.46%) |
Filing History |
| 2023-10-20 2:02 pm Sale |
2023-10-11 | 13G | Silk Road Medical, Inc SILK |
James E. Flynn | 0 0.000% |
-1,396,640 (Position Closed) |
Filing History |
| 2023-10-18 4:41 pm Purchase |
2023-10-09 | 13G | DocGo Inc. DCGO |
James E. Flynn | 6,014,750 5.800% |
6,014,750 (New Position) |
Filing History |
| 2023-10-04 5:09 pm Sale |
2023-10-04 | 13G | Terns Pharmaceuticals, Inc. TERN |
James E. Flynn | 0 0.000% |
-2,851,287 (Position Closed) |
Filing History |
| 2023-10-04 5:08 pm Sale |
2023-10-04 | 13G | Evolus, Inc. EOLS |
James E. Flynn | 1,784 0.000% |
-3,317,216 (-99.95%) |
Filing History |
| 2023-09-21 4:55 pm Purchase |
2023-09-14 | 13G | Kura Oncology, Inc. KURA |
James E. Flynn | 4,374,044 5.890% |
1,991,044 (+83.55%) |
Filing History |
| 2023-08-30 08:07 am Purchase |
2023-08-22 | 13G | Invitae Corporation NVTAQ |
James E. Flynn | 93,062,106 4.900% |
92,895,440 (+55737.49%) |
Filing History |
| 2023-08-14 5:07 pm Sale |
2023-08-09 | 13G | Singular Genomics Systems, Inc. OMIC |
James E. Flynn | 263,889 7.400% |
-35,474 (-11.85%) |
Filing History |
| 2023-06-22 5:46 pm Purchase |
2023-06-21 | 13G | Verastem, Inc. VSTM |
James E. Flynn | 1,538,461 6.100% |
1,538,461 (New Position) |
Filing History |
| 2023-06-09 4:15 pm Purchase |
2023-06-09 | 13G | GeneDx Holdings Corp. WGS |
James E. Flynn | 1,253,895 4.900% |
1,253,895 (New Position) |
Filing History |
| 2023-05-26 3:09 pm Purchase |
2023-05-22 | 13G | Cabaletta Bio, Inc. CABA |
James E. Flynn | 2,340,118 5.900% |
1,875,866 (+404.06%) |
Filing History |
| 2023-05-23 5:25 pm Sale |
2023-05-19 | 13D | CalciMedica, Inc. CALC |
James E. Flynn | 276,798 4.890% |
-100,466 (-26.63%) |
Filing History |
| 2023-05-18 4:05 pm Purchase |
2023-05-11 | 13G | Amedisys, Inc. AMED |
James E. Flynn | 1,794,000 5.510% |
1,794,000 (New Position) |
Filing History |
| 2023-05-10 12:51 pm Sale |
2023-05-10 | 13G | Rain Enhancement Technologies Holdco Inc RAIN |
James E. Flynn | 0 0.000% |
-2,796,261 (Position Closed) |
Filing History |
| 2023-05-03 4:58 pm Sale |
2023-05-03 | 13G | Mirum Pharmaceuticals, Inc. MIRM |
James E. Flynn | 0 0.000% |
-2,032,335 (Position Closed) |
Filing History |
| 2023-04-06 4:50 pm Purchase |
2023-03-31 | 13G | Owens & Minor, Inc. OMI |
James E. Flynn | 4,202,667 5.510% |
4,202,667 (New Position) |
Filing History |